Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_94928c6d96e137fec9d5926282673399 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e9995dadfe807670ea8301540327a69a http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_03c6da2e53d8ebb6a767d479693a0103 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_015d96379a85b582c85891bc267b8af5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ffc7a1c7c32d86d64f60f157c2278dd9 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-84 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-72 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44 |
filingDate |
2005-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36a99d51f50ca108812dbf3d6ffd5401 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_601162aeddd2f6bc848365aedd861b2c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d991005b9aba591a1dc1cd10dd151d14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_85dd3e69cf54850178de712fbb870ba9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37bbc974793f63afc32c5c8ad101c49e |
publicationDate |
2006-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2006025455-A1 |
titleOfInvention |
New 5-aryl pyridines as 11-beta inhibitors for the treatment of diabetes |
abstract |
Compounds of formula (I): n nas well as pharmaceutically acceptable salts and esters thereof used in the form of pharmaceutical compositions. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010029648-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007027118-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007092435-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7632838-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9458147-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9884826-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10370333-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015011551-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105175323-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007219198-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007092435-A2 |
priorityDate |
2004-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |